Please assess the completion status of the following clinical trial:

Trial Title: Clinical Evaluation of Using Intense Pulsed Light for Improving the Appearance of Striae Distensae

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Able to provide written Informed Consent;~2. Healthy male or female, 24-65 years Fitzpatrick-Goldman skin type I-V;~3. Having visible Striae Distensae to be treated (abdomen/thighs);~4. Comply with the treatment/follow-up schedule and requirements;~5. Women of child-bearing age are required to be using a reliable method of birth control~Exclusion Criteria:~1. Fitzpatrick-Goldman skin type VI;~2. Pregnant, intending to become pregnant during the course of study, less than 3 months postpartum or less than 6 weeks after breastfeeding;~3. Heavy smoker~4. Unable or unlikely to refrain from tanning~5. Use of photosensitive medication~6. Use of oral isotretinoin within 3 months~7. Any dermal/epidermal damage or disorder in treated area~8. Prior treatment in treated area within 3 months~9. Prior skin laser/light or another device treatment in treated area within 6 months~10. Prior use of collagen, fat injections or other methods of skin augmentation in treated area within 12 months~11. Prior use of Botox in treatment area within 6 months~12. Prior ablative resurfacing procedure with laser in treatment area within 12 months~13. Any other surgery in treated area within 9 months~14. Participation in a study of another investigational device or drug as per the Investigator's discretion~15. History of keloid or any other type of hypertrophic scar formation or poor wound healing in a previously injured skin area~16. Showing symptoms of hormonal disorders (such as Melasma, Chloasma);~17. Concurrent inflammatory skin conditions, open laceration or abrasion of any sort on area to be treated during the course of treatment~18. Active Herpes Simplex at the time of treatment or having experienced more than three episodes of Herpes Simplex eruption within a year of study~19. Multiple dysplastic nevi in area to be treated~20. Having a bleeding disorder or taking anticoagulation medications~21. History of immunosuppression/immune deficiency disorders~22. Having any form of active cancer at the time of enrollment and during the course of the study or history of skin cancer~23. Pigmented lesion in the treated area that appears cancerous~24. Significant concurrent illness, such as uncontrolled diabetes~25. Active infections in the treated area~28.Tattoo or permanent makeup at the treatment area. 29.Mentally incompetent, prisoner or evidence of active substance or alcohol abuse 30.Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study

- Gender: ALL
- Minimum Age: 24 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): Group receiving treatment with Venus Versa IPL energy

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy